Daniel C. Adelman, MD, is Aimmunes’s Chief Medical Officer. As an allergist and immunologist, he has led drug development at biotechnology companies for more than 20 years and taught and practiced medicine at the University of California, San Francisco, for more than 25 years. Most recently, Dr. Adelman spent seven years as Chief Medical Officer and Senior Vice President of Development at Alvine Pharmaceuticals, a biopharmaceutical company focused on autoimmune and inflammatory diseases, particularly celiac disease. He held the same positions, as Chief Medical Officer and Senior Vice President of Development, during five years at Sunesis Pharmaceuticals, Inc. Earlier, Dr. Adelman served in various roles at Pharmacyclics, Inc., including Vice President of Clinical Operations and Biometrics, and was a Clinical Scientist at Genentech, Inc.
Dr. Adelman has published extensively in allergy, clinical immunology and autoimmunity, and oncology. He served on the Research Advisory Board of Food Allergy Research & Education (FARE) for more than five years and on the editorial board of the Journal of Allergy and Clinical Immunology for five years. He now serves on several clinical scientific advisory boards and on the editorial boards of Clinical Immunology and Journal of Clinical Immunology. Dr. Adelman holds a bachelor’s degree in biology from the University of California, Berkeley, and earned his MD from the University of California, Davis.
A popular speaker, she delivers presentations at medical, nutrition, celiac and food industry conferences throughout North America. Shelley’s best-selling book Gluten Free: The Definitive Resource Guide is highly recommended by health professionals, celiac organizations, consumers and the food industry. Author of many journal articles on celiac disease and the gluten-free diet, she also contributes to a variety of other publications for health professionals and consumers. Her column “Ask the Celiac Expert” is featured in Allergic Living magazine.
In recognition of Shelley’s major contributions to the field of celiac disease and her dedication to educating health professionals and individuals with celiac disease in North America, she was awarded the Queen Elizabeth Golden Jubilee Medal.
Professionally, Shelley is a member of the Academy of Nutrition and Dietetics, as well as the Nutrition Entrepreneurs, Dietitians in Business and Communications, Food and Culinary Professionals and the Medical Nutrition Practice Groups of the Academy of Nutrition and Dietetics as well as the Dietitians of Canada. Shelley lives in Regina, Saskatchewan, Canada with her husband and daughter.
Dr. Crowe is a Professor in the Division of Gastroenterology in the Department of Medicine at the University of California in San Diego (UCSD). She received her medical degree in 1982 from McMaster University in Hamilton, Ontario, Canada, and completed postgraduate training in internal medicine and gastroenterology at McMaster University. After additional research training in the Intestinal Diseases Research Unit at McMaster University and at the University of Toronto, she joined the faculty at McMaster University before moving to the United States in 1992. She spent 9 years at the University of Texas Medical Branch in Galveston where she served as the Gastroenterology Fellowship Training Program Director before moving to the University of Virginia in 2001. There she served as the Director of the UVA Celiac Disease Center, Director of Endoscopy in the UVA Outpatient Surgical Center, Director of the Training in Digestive Diseases T32 Grant, and a member of the Department of Medicine Committee Residency Education. She joined UCSD in July 2011 as the Director of Research in the Division of Gastroenterology and Director of the UCSD Gastroenterology T32 Training Grant.
As a clinician-scientist, Dr. Crowe is dedicated to conducting research, providing clinical care and teaching and mentoring medical students. Her clinical interests include H. pylori infection, acid-peptic diseases, infectious GI diseases, celiac disease, gluten sensitivity, food allergies and colorectal cancer screening methods. Her research is focused on understanding the immune-epithelial interactions involved in gastrointestinal diseases. She has received ongoing funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for her work studying the role of oxidative stress in gastric epithelial injury related to H. pylori infections.
During her medical training, Dr. Crowe completed her gastroenterology fellowship and her residency and internship in internal medicine at McMaster University. She also earned her medical degree from McMaster University.
Dr. Crowe is a fellow of the American Gastroenterological Association (AGA) and serves as councillor-at-large on the organization’s Governing Board. She also chairs the AGA Publication Committee and is the editor of AGA Perspectives.
Dr. Crowe is a fellow of the Royal College of Physicians of Canada, the American College of Physicians and the American College of Gastroenterology. She serves on the medical advisory boards for the Celiac Disease Foundation and the National Foundation for Celiac Awareness and on the editorial boards for the American Journal of Physiology – Gastrointestinal and Liver Physiology, Alimentary Pharmacology & Therapeutics, Mucosal Immunology, and Clinical Gastroenterology and Hepatology.
Dr. Crowe has been listed annually in America’s Best Doctors in America, published by Castle Connolly Medical Ltd., since 1996. Dr. Crowe has received several awards from the American Gastroenterological Association, including the 2008 Outstanding Woman in Science, the 2008 Funderburg Award for her gastric cancer research, and the 2013 Distinguished Educator Award. In 2010 Dr. Crowe was named in Becker’s ACS as one of 75 top gastroenterologists in the USA and in 2011 she was listed as one of Virginia and Washington DC’s “Top Doctors” in Virginia Living Magazine.
Dr. Crowe is the author of many articles and book chapters and was a contributing author for the book Celiac Disease for Dummies, published in 2010. From 2009 to 2010, she served as a consultant on topics related to celiac disease for the health section of The New York Times online.
World-renowned pediatric gastroenterologist, research scientist, and entrepreneur Alessio Fasano, M.D., founded the Center for Celiac Research in 1996. The Center offers state-of-the art research, clinical expertise, and teaching for the diagnosis, treatment, and prevention of gluten-related disorders, including celiac disease, non-celiac gluten sensitivity, and wheat allergy.
Trained in Naples, Italy, as a pediatric gastroenterologist, Dr. Fasano was recruited to the University of Maryland School of Medicine in 1993 and founded its Division of Pediatric Gastroenterology and Nutrition. Puzzled by the absence of children exhibiting symptoms of celiac disease in the clinic, he resolved to uncover the mystery of missing American “celiacs.” His perseverance in the face of skepticism about celiac disease in the U.S. eventually led to his publication of the groundbreaking study in 2003 that established the rate of the autoimmune disorder at one in 133 Americans.
In early 2013, Dr. Fasano was appointed Division Chief of Pediatric Gastroenterology and Nutrition at MassGeneral Hospital for Children. He brought the Center for Celiac Research to Boston, where he and his team of clinicians treat patients of all ages. Dr. Fasano also heads the Mucosal Immunology and Biology Research Center, based in Charlestown, and is Associate Chief for Basic, Clinical and Translational Research for the Department of Pediatrics at MassGeneral Hospital for Children. He is a Visiting Professor of Pediatrics at Harvard Medical School.
Peter HR Green, MD, is Director of the Celiac Disease Center at Columbia University in New York and the Phyllis and Ivan Seidenberg Professor of Medicine at Columbia University Medical Center. He is also Attending Physician at the New York Presbyterian Hospital. Dr. Green received his medical degree from the University of Sydney. He completed Residency and Gastrointestinal Fellowship in Sydney and became a Research Fellow at Harvard Medical School and at the Beth Israel Hospital in Boston. Subsequently he moved to the Columbia University Medical Center where he has remained.
Celiac disease has been his clinical and research focus for the last thirty years. He started the Celiac Disease Center at Columbia University Medical Center and it has risen to National and International preeminence since its inception in 2001. Both adult and pediatric gastroenterologists see thousands of patients annually in the Celiac Disease Center at Columbia University.
Dr. Green has authored over 300 research publications on celiac disease and lectured widely to medical students, medical professionals and the public about gluten-related disorders. He performs clinical, epidemiological and basic research on celiac disease and other gluten-related disorders. He has authored many of the most recent medical reviews on celiac disease, published in the New England Journal of Medicine, The Lancet, The BMJ, Annals of Internal Medicine and JAMA.
In 2007 he was awarded a Mentors Research Scholar Award from the American Gastroenterology Association and Master Endoscopist Award from the American Society for Gastrointestinal Endoscopy. He is a previous president of the New York Society for Gastrointestinal Endoscopy and is a recent President of the North American Society for the Study of Celiac Disease (NASSCD). He is a fellow of the Royal Australasian College of Physicians and the American College of Gastroenterology as well as a member of the American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy.
He has co-authored two books for the public: Celiac Disease, a hidden epidemic, and Gluten Exposed: The Science Behind the Hype and How to Navigate to a Healthy, Symptom-Free Life, both published by Harper Collins.
Dr. Green is on the scientific and medical advisory board of several companies developing pharmaceutical therapies for celiac disease.
Stefano Guandalini, MD, is an internationally recognized expert on celiac disease and is also known for his expertise in the research and treatment of other diarrheal diseases in children.
Dr. Guandalini’s clinical and research efforts have greatly influenced the way celiac disease is diagnosed and treated today. His work contributed to the revision of 20-year-old guidelines for celiac disease diagnosis. These guidelines are now used worldwide for the diagnosis of celiac disease in both children and adults.
Dr. Guandalini created the University of Chicago Celiac Disease Center in response to the low rate of celiac disease detection in the United States. This innovative program is dedicated to patient care services, research activities, medical education, and public awareness initiatives in order to increase the rate of celiac diagnoses and improve the lives of celiac patients. The Celiac Disease Center serves patients of all ages.
Dr. Guandalini is the past president of the Federation of International Societies for Pediatric Gastroenterology, Hepatology, and Nutrition. He was selected from a worldwide pool of candidates to be the first president of this federation.
Dr. Hill is a pediatric gastroenterologist and internationally known celiac disease researcher. He completed his M.D. from the University of Cape Town in South Africa in 1982 and is currently listed in Best Doctors of America. His clinical specialties include malabsorption syndromes, functional gastrointestinal disorders, inflammatory bowel disease, celiac disease, pancreatic diseases, diseases of the intestines, liver disease, and nutritional disorders. His recent publications can be viewed at http://www.wakehealth.edu/Faculty/Hill-Ivor-D.htm.
Edward J. Hoffenberg, MD, earned his medical degree from Case Western Reserve University School of Medicine in Cleveland, Ohio, in 1986. He completed his Pediatric Residency at the Rainbow Babies and Children’s Hospital in Cleveland, Ohio, in 1989. Dr. Hoffenberg completed his Fellowship in Pediatric Gastroenterology and Nutrition in 1992 at the Children’s Hospital of Philadelphia and the University of Pennsylvania School of Medicine. He joined the faculty of the Department of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado in 1992. He has been Medical Director of the Program for Pediatric Inflammatory Bowel Diseases at Children’s Colorado since 1998.
Dr. Hoffenberg’s research interests include epidemiology and the clinical features of celiac autoimmunity in early childhood, inflammatory bowel disease and inherited polyposis syndromes. He has received grant support for numerous research projects. and currently provides gastroenterology services in Denver, CO.
Dr. Kasarda received his PhD in physical chemistry from Princeton University. Subsequently, he held research positions with Bell Laboratories, Murray Hill, NJ, and the Cardiovascular Research Institute, University of California Medical School, San Francisco, CA.
He then joined the USDA’s Western Regional Research Center in Albany, CA, where he was a research chemist, project leader, and research unit leader until his retirement in 1999. He retains an association with the Center as a Collaborator. Dr. Kasarda is also an Associate in the Experiment Station at the University of California, Davis, in the Department of Plant Sciences. His research has focused on the structure of grain storage proteins, especially the gluten proteins of wheat, and, for the past 40 years, has collaborated with various medical research groups in attempts to define the basis for the activity of these proteins in celiac disease.
He serves as an advisor to several celiac patient support groups, providing dietary guidance concerning the safety of various grains and of processed foods that might contain active wheat, rye, or barley proteins (or active peptide fragments derived from them).
Daniel Leffler, MD, MS currently serves as the Director of Research at the Celiac Center at Beth Israel Deaconess Medical Center, as the Director of Quality Improvement for the Division of Gastroenterology at BIDMC and is an Associate Professor of Medicine at Harvard Medical School.
Dr. Leffler currently divides his time between patient care, quality improvement initiatives and clinical and translational research in celiac disease and other digestive disorders. To continue his work in celiac disease, Dr. Leffler has been awarded a five year career development grant from the National Institute of Health and has been the recipient of multiple foundation and industry sponsored grants for the advancement of digestive health. He lectures nationally and internationally on these topics and has co-authored a book for patients entitled: Real Life with Celiac Disease. Troubleshooting and Thriving Gluten Free, published by the American Gastroenterological Association.
Dr. Malahias received a bachelor’s degree in pharmacy from Albany College of Pharmacy in 1982. He received his DDS from the State University of New York at Stony Brook School of Dental Medicine in 1990. He completed his dental residency at St. Charles Hospital and Rehabilitation Center in Port Jefferson New York in 1991.
Dr. Malahias practiced for a short while in New York before joining FHP Health Care Corporation of California through whom he worked in Guam and Utah. Dr. Malahias is an affiliate of the Celiac Disease Center at Columbia University. He has conducted research on the association of celiac disease and dental enamel defects. Dr. Malahias has lectured at many major celiac conferences throughout the United States and has presented at the International meeting in 2006. Dr Malahias is a member of the American Dental Association and the Academy of General Dentistry. He enjoys traveling, boating, music, and woodwork.
Joseph A. Murray, M.D. serves as a Gastroenterologist in the Division of Gastroenterology and Hepatology at the Mayo Clinic in Rochester, Minnesota. He founded a celiac disease clinic at the University of Iowa in 1992. In 1998, Dr. Murray joined the staff of Mayo clinic, where he runs the celiac disease research and clinical program that focuses on epidemiology, complications and mouse models of gluten sensitivity. In addition, Dr. Murray is a Professor of Medicine at the Mayo clinic in Rochester, Minnesota. He serves as a Consultant to several companies and has broad experience with clinical trials. Dr. Murray is an Associate Editor of Clinical Gastroenterology and Hepatology as well as an expert reviewer for many scientific journals. He has published over 100 scientific articles and has several patents on novel devices for the treatment of GI disorders. He has a large clinical practice widely focused on celiac disease and has been elected to the Best doctors in America from 2001 to 2006. He received his medical training in Ireland and GI training from the University of Iowa.
Cynthia S. Rudert, M.D., F.A.C.P., is a board-certified gastroenterologist in Atlanta, Georgia, whose practice is primarily devoted to the screening and following of patients with celiac disease. With one of the largest practices in the United States that manages adults and teenagers with celiac, she has evaluated over 1000 patients with celiac disease and gluten sensitivity. Committed to educating the public, patients, and physicians about this commonly missed disorder, Dr. Rudert lectures throughout the United States and Canada on celiac disease. She also lectures on inflammatory bowel disease, irritable bowel syndrome, pancreatic exocrine insufficiency, and small intestinal bacterial overgrowth.
Dr. Rudert sees patients from all over the United States for second-opinion consults on a variety of gastrointestinal disorders. Dr. Rudert’s focus is identifying the core causes of gastrointestinal issues with a comprehensive evaluation, enabling her to treat underlying medical conditions that may have previously been undetected. Dr. Rudert then creates an individualized course of treatment tailored to each patient’s unique set of needs. Rather than treating just the symptoms of disease, Dr. Rudert believes the best results are achieved by getting to the core cause of the problem and treating the disease accordingly.
Dr. Rudert is Medical Advisor for the Celiac Disease Foundation, the Gluten Intolerance Group of North America, and for the Gluten Free Certification Organization (GFCO). She is Medical Director for Atlanta Gluten Intolerance Group (GIG), and founder and president of the Atlanta Women’s Medical Alliance, the largest alliance of female physicians in the United States. In demand as an expert in celiac disease, she was the keynote speaker for multiple programs including the New England Celiac Conference, co-hosted with the Beth Israel Deaconess Medical Center/Harvard, and national GIG meetings. Dr. Rudert was the advising physician for the popular television series House which featured a segment concerning celiac. Dr. Rudert was a former assistant professor of medicine with Emory University.
Dr. Weiss practices general gastroenterology, with particular interests in gluten-associated disorders (including celiac disease and non-celiac gluten/wheat sensitivity), food allergies, and inflammatory bowel diseases. His research focuses on adherence to medical therapy and diet, gluten-associated disorders, IBD, and outcomes research. Dr. Weiss studied in the combined BMedSc/MD program at the Sackler School of Medicine, Tel Aviv University, Israel. He completed his internal medicine training at SUNY Buffalo, NY and served as a chief resident during his third year. He subsequently completed his gastroenterology fellowship at UCLA. During his training, Dr. Weiss developed the UCLA Celiac Collective, and after graduating, joined the Westwood faculty and was appointed as the UCLA Celiac Program Leader.
John J. Zone, MD, has specialized expertise in the diagnosis and treatment of blistering diseases of the skin. He runs both a research and clinical laboratory dedicated to diagnosis, treatment and research of these blistering diseases. In addition, he is board certified in dermatology, immunodermatology and internal medicine. Dr. Zone deals primarily with the practice of medical dermatology and expert management of dermatitis herpetiformis, gluten intolerance, linear IgA disease, pemphigus, pemphigoid, lichen planus and oral ulcers that are frequently related to immune conditions.
Dr. Zone has been Head of Dermatology at the University of Utah since 1987. Since that time, the Department has achieved national recognition for its clinical and educational programs as well as its basic and clinical research in diseases and cancer of the skin. He has nurtured and supported strong faculty development in all clinical areas of dermatology, including research programs in psoriasis, bullous disease, melanoma, genetics of skin disease and genetic epidemiology.